Acquisitions contributed an additional 6% to sales, including Dipsol and Sutai.
Adjusted EBITDA was $75.5 million with margins of 15.6%, reflecting sales growth and disciplined cost management.
Capital expenditures were approximately $8 million, focused on new facility construction in China.
GAAP diluted earnings per share were a loss of $3.78 due to a noncash goodwill impairment charge and a $9 million restructuring charge.
Gross margins were 36%, slightly lower than prior periods but within target range, impacted by higher raw material and manufacturing costs and product/geographic mix.
Gross margins were 36%, slightly lower than prior year due to higher raw material and manufacturing costs and product/geographic mix.
Net debt was $735 million with a net leverage ratio of 2.6x trailing 12 months adjusted EBITDA.
Non-GAAP diluted earnings per share were $1.71.
Operating cash flow was $42 million in the quarter, with working capital as a source of cash.
Operating cash flow was $42 million, with $33 million used for share repurchases.
Organic volumes increased 2%, driven by new business wins of approximately 5% and continued strength in Asia/Pacific.
Second quarter net sales were $483 million, a 4% increase from the prior year.
Dafinchi